Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium

Fig. 1

Age, sex, comorbidity and drug standardized 60-day risk of all-cause death in relation to plasma potassium as a continuous variable. Model adjusted for age, gender, plasma sodium, renal insufficiency, malignancy, heart failure, chronic liver disease, chronic obstructive pulmonary disease, diabetes mellitus, atrial flutter/fibrillation, stroke and ischemic heart disease, antihypertensive therapy, corticosteroids, antimicrobials, non-steroidal anti-inflammatory drugs, potassium supplement, xanthines, laxatives

Back to article page